BTKi Treatment for Chronic Lymphocytic Leukemia
Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic Lymphoma
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute · Other
This trial is looking for adults with chronic lymphocytic leukemia who are starting a specific type of treatment. Participants will help researchers understand how treatment affects quality of life and symptoms over two years.
You may be able to join if
- I have been diagnosed with chronic lymphocytic leukemia.
- I am starting treatment with a BTKi or BCL2i with Obinutuzumab.
- I can read and speak English or Spanish at the 8th grade level.
You may not be able to join if
- I have dementia.
- I have had a traumatic brain injury.
- I have central nervous system involvement of my leukemia.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThe study aims to improve our understanding of how quality of life, fatigue, and symptoms change over 2 years when participants are treated for chronic lymphocytic leukemia or small lymphocytic lymphoma. We will compare two types of treatment to help future patients with chronic lymphocytic leukemia or small lymphocytic lymphoma know what to anticipate.
Loading trial locations…